A set of tools NASA developed assessing new, rapidly developed and deployed technology could help biopharmas adopt advanced tech post-commercialization.
- How To Leverage Platform And Process Characterization Data To Accelerate Cell & Gene Therapies
- Complex Protein Development: Assay Early, Assay Often
- Wish SUS Cost Less? Survey Says Your Peers Do, Too
- A Year In, Sanofi's Journey With Plai AI Is Aiding Quality Decisions
- Capacity, AI Driving Single-use Bioprocess Probe And Sensor Uptake
- Delivering Large Molecules To The CNS, Overcoming The Blood-Brain Barrier
- Luxturna Maker Spark Therapeutics' Flexible Platform Approach
EDITOR'S DESK
-
Key Takeaways From The 2024 Bioprocessing Summit
Editor Tyler Menichiello reflects on the topics and trends covered at this year's Bioprocessing Summit in Boston.
Where there is therapeutic demand, the industry will build capacity. But with ADCs, cytotoxic payloads and a fragmented contract manufacturing landscape make the path to clinical and commercial supply dauntingly complicated. Here's how the ADC manufacturing market is shaping up, and how it might ultimately shake out.
The wave of ADC (antibody-drug conjugate) development and manufacturing activity we’re currently witnessing, and importantly, the HPC (high-potency compounds) comprising the payloads in these therapies, demand thorough assessment of development and manufacturing facility design.
Half of respondents to a recent survey of biopharmaceutical companies said the greatest challenge in further growing industry acceptance of single-use technology—which now comprises an eye-popping 85% of non-commercial-scale biopharma manufacturing infrastructure—is the greater challenge in further growing industry acceptance of single-use technology
Experts from last month’s Cell & Gene Live event discuss practical ways to utilize emerging technologies.
GUEST COLUMNISTS
-
Wish SUS Cost Less? Survey Says Your Peers Do, Too
BioPlan Associates 21st Annual Report found biopharma companies want lower cost single-use system options over any other new product development area.
-
Capacity, AI Driving Single-use Bioprocess Probe And Sensor Uptake
Disposable probes and sensors offer advantages over their reusable counterparts, especially as industry moves toward flexible, scalable production models.
-
A Year In, Sanofi's Journey With Plai AI Is Aiding Quality Decisions
Sanofi has been a vocal of advocate of AI/ML for years. Here's how it's using technology to facilitate the audit process and get to the bottom of deviations faster.
-
Luxturna Maker Spark Therapeutics' Flexible Platform Approach
The company proved the concept by bringing to market its AAV-based gene therapy for an inherited form of vision loss.
-
The Small Biotech's Checklist For FIH Trials
Getting medicine to its first patients is enormously complex with many players and moving parts. These are the critical steps.
-
How To Minimize The Impact Of Stability Testing On Gene Therapy Batch Yield
This article outlines strategies for reducing the volumes required for gene therapy stability studies, with the goal of conserving product for patients, while remaining compliant and delivering data on CQAs.
-
Drug Product Formulation & Process Development: The Must-Have Skills At A Glance
Specialists in drug product formulation and process development at small biopharmas need to balance scientific knowledge and multidisciplinary know-how across the stages of product development.
-
Tips For Deploying Advanced Modeling In Commercial Phase Bioprocessing
In-silico tools are ubiquitous in development, but big hurdles prevent them from showing up meaningfully in commercial manufacturing. These tips could help clear them.
BIOPROCESSING WHITE PAPERS
-
The Heroes Of Vaccine Development: Lipid Nanoparticles
Lipid nanoparticles (LNPs) have played a crucial role in COVID-19 vaccine development as efficient mRNA delivery systems, exhibiting versatility and effectiveness in accelerating the process.
-
Assurance Of Clonality For Biotherapeutics10/13/2022
The clonality of Master Cell Banks (MCBs) for production cell lines is a key requirement in biotherapeutics manufacturing. Learn how new devices help optimize the cloning process.
-
Advancing API Development With Aseptic Manufacturing And Processing5/16/2024
Delve into the complexities of API sterilization and gain insight from best practices and the critical role of expertise in maintaining sterile production environments.
-
The Role Of Extractables Data In The Adoption Of Single-Use Systems8/29/2024
Explore guidance for evaluating single-use systems for extractables and leachables, and learn how supplier-provided single-use system extractables data can save both time and resources.
-
Purity Analysis Methods For Synthetic Prime Editing Guide RNAs9/8/2023
Develop a fast, easy workflow for the purity analysis of complex pegRNA molecules along with a robust denaturing technique for pegRNA with high levels of secondary structure.
-
Bispecific Antibodies Unleashed5/16/2024
Explore how leveraging expert CDMO partnerships can streamline the development process and enhance the efficacy of your bispecific antibody therapies.
BIOPROCESSING APP NOTES & CASE STUDIES
BIOPROCESS ONLINE CONTENT COLLECTIONS
This collection of articles, produced through a partnership between MilliporeSigma and Bioprocess Online, highlights the need for ongoing investment in resilient biomanufacturing capacity and supply chains to ensure the reliable delivery of health technologies like vaccines, even during crisis conditions.
More Content CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
- Navigating Challenges During Formulation Development
- Formulation Considerations For The Development Of High Concentration Biopharmaceuticals
- Maximize Quality Assurance Through Rapid Sterility Testing
- Intensifying Downstream Bioprocessing With Continuous Technologies
- Innovations In Perfusion Bioprocessing
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 09.14.24 -- Bioprocess Online Best Of August
- 09.13.24 -- The Importance Of Transparency In Fruitful Outsourcing Relationships
- 09.13.24 -- DSCSA Implementation Is Progressing, But More Complexity May Be Coming
- 09.12.24 -- Outsourcing Strategies To Maximize RNA-LNP Success
- 09.12.24 -- A Year In, Sanofi's Journey With Plai AI Is Aiding Quality Decisions